TH0401003368A - Use of modified cyclosporine for the treatment of HCV disorders - Google Patents

Use of modified cyclosporine for the treatment of HCV disorders

Info

Publication number
TH0401003368A
TH0401003368A TH0401003368A TH0401003368A TH0401003368A TH 0401003368 A TH0401003368 A TH 0401003368A TH 0401003368 A TH0401003368 A TH 0401003368A TH 0401003368 A TH0401003368 A TH 0401003368A TH 0401003368 A TH0401003368 A TH 0401003368A
Authority
TH
Thailand
Prior art keywords
treatment
cyclosporine
hcv
disorders
modified
Prior art date
Application number
TH0401003368A
Other languages
Thai (th)
Other versions
TH141648A (en
Inventor
ฮิจิกาตะ นายคูนิทาดะ ชิโมโตห์โนะ นายโคอิชิ วาตาชิ นายมาโกโตะ
Original Assignee
โนวาร์ทิส เอจี
Filing date
Publication date
Application filed by โนวาร์ทิส เอจี filed Critical โนวาร์ทิส เอจี
Publication of TH0401003368A publication Critical patent/TH0401003368A/en
Publication of TH141648A publication Critical patent/TH141648A/en

Links

TH401003368A 2004-08-30 Use of modified cyclosporin for the treatment of HCV disorders TH141648A (en)

Publications (2)

Publication Number Publication Date
TH0401003368A true TH0401003368A (en) 2015-06-29
TH141648A TH141648A (en) 2015-06-29

Family

ID=

Similar Documents

Publication Publication Date Title
DK1663287T3 (en) Use of modified cyclosporins for the treatment of HCV diseases
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
DE602005026984D1 (en) CHINOLIN DERIVATIVES FOR THE TREATMENT OF LATENTE Tuberculosis
DE602006016150D1 (en) PREVENTION OF DISEASES AT KAISERSCHNITT-BABIES
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
NO20070251A (en) Well treatment
DE602005023172D1 (en) HYDANTINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES
NO20070297A (en) Well treatment
EP1928453A4 (en) Methods and compositions for the preventioin and treatment of kidney disease
ATE493986T1 (en) DIARYLUREAS FOR THE TREATMENT OF PULMONARY HYPERTENSION
DK1491212T3 (en) Means for the treatment of sleep disorders
DE602005016141D1 (en) S-MIRTAZAPINE FOR THE TREATMENT OF HITZEWALLUNGEN
DK3332789T3 (en) CLADRIBINCUR FOR THE TREATMENT OF MULTIPLE SCLEROSIS
EP1805210A4 (en) Novel peptides and methods for the treatment of inflammatory disease
GB2411354B (en) Use of Scutellaria for the treatment of viral infections
ATE503752T1 (en) SULFAMIDE ALSENDOTHELIN RECEPTOR ANTAGONSITES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
NO20070042L (en) Treatment of hydrocarbons
DK1940447T3 (en) TREATMENT OF NEURODEGENRATIVE DISORDERS
ATE446757T1 (en) 1-Ä2H-1-BENZOPYRAN-2-ONE-8-YLÜ-PIPERAZINE DERIVATIVE FOR THE TREATMENT OF MOVEMENT DISORDERS
DE602004011679D1 (en) Treatment of disorders
TH0401003368A (en) Use of modified cyclosporine for the treatment of HCV disorders
DE602006016469D1 (en) MEANS FOR THE TREATMENT OF REPRODUCTION DISORDERS
DK1594498T3 (en) Use of etazolate for the treatment of diseases
EE200400064A (en) Use of ambroxol for the treatment of pharyngitis